As of Feb 23
| +0.70 / +8.33%|
The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 19.50, with a high estimate of 30.00 and a low estimate of 9.00. The median estimate represents a +114.29% increase from the last price of 9.10.
The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.